|
1
|
Schiller JH, Harrington D, Belani CP, et
al; The Eastern Cooperative Oncology Group. Comparison of four
chemotherapy regimens for advanced non-small-cell lung cancer. N
Engl J Med. 346:92–98. 2002. View Article : Google Scholar
|
|
2
|
Phillips DH: Smoking-related DNA and
protein adducts in human tissues. Carcinogenesis. 23:1979–2004.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Annual reports of the Department of
Health, the Executive Yuan, Taiwan, Republic of China, 2012.
|
|
4
|
Moran CA and Suster S: Tumours of the lung
and pleura. Diagnostic Histopathology of Tumours. Fletcher CDM:
Churchill Livingstone; London: pp. 171–208. 2000
|
|
5
|
Ko YC, Lee CH, Chen MJ, et al: Risk
factors for primary lung cancer among non-smoking women in Taiwan.
Int J Epidemiol. 26:24–31. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hung JJ, Wang CY, Huang MH, Huang BS, Hsu
WH and Wu YC: Prognostic factors in resected stage I non-small cell
lung cancer with a diameter of 3 cm or less: visceral pleural
invasion did not influence overall and disease-free survival. J
Thorac Cardiovasc Surg. 134:638–643. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Browman GP, Wong G, Hodson I, et al:
Influence of cigarette smoking on the efficacy of radiation therapy
in head and neck cancer. N Engl J Med. 328:159–163. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Johnston-Early A, Cohen MH, Minna JD, et
al: Smoking abstinence and small cell lung cancer survival. An
association. JAMA. 244:2175–2179. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Videtic GM, Stitt LW, Dar AR, et al:
Continued cigarette smoking by patients receiving concurrent
chemoradiotherapy for limited-stage small-cell lung cancer is
associated with decreased survival. J Clin Oncol. 21:1544–1549.
2003. View Article : Google Scholar
|
|
10
|
Hoffmann D, Lavoie EJ and Hecht SS:
Nicotine: a precursor for carcinogens. Cancer Lett. 26:67–75. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Minna JD: Nicotine exposure and bronchial
epithelial cell nicotinic acetylcholine receptor expression in the
pathogenesis of lung cancer. J Clin Invest. 111:31–33. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Garnier M, Lamacz M, Tonon MC and Vaudry
H: Functional characterization of a nonclassical nicotine receptor
associated with inositolphospholipid breakdown and mobilization of
intracellular calcium pools. Proc Natl Acad Sci USA.
91:11743–11747. 1994. View Article : Google Scholar
|
|
13
|
Jull BA, Plummer HK III and Schuller HM:
Nicotinic receptor-mediated activation by the tobacco-specific
nitrosamine NNK of a Raf-1/MAP kinase pathway, resulting in
phosphorylation of c-myc in human small cell lung carcinoma cells
and pulmonary neuroendocrine cells. J Cancer Res Clin Oncol.
127:707–717. 2001.
|
|
14
|
Masaki T, Igarashi K, Tokuda M, et al:
pp60c-src activation in lung adenocarcinoma. Eur J Cancer.
39:1447–1455. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Park PG, Merryman J, Orloff M and Schuller
HM: Beta-adrenergic mitogenic signal transduction in peripheral
lung adenocarcinoma: implications for individuals with preexisting
chronic lung disease. Cancer Res. 55:3504–3508. 1995.PubMed/NCBI
|
|
16
|
Schuller HM and Cekanova M: NNK-induced
hamster lung adenocarcinomas over-express beta2-adrenergic and EGFR
signaling pathways. Lung Cancer. 49:35–45. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tsurutani J, Castillo SS, Brognard J, et
al: Tobacco components stimulate Akt-dependent proliferation and
NFkappaB-dependent survival in lung cancer cells. Carcinogenesis.
26:1182–1195. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
West KA, Brognard J, Clark AS, et al:
Rapid Akt activation by nicotine and a tobacco carcinogen modulates
the phenotype of normal human airway epithelial cells. J Clin
Invest. 111:81–90. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
West KA, Linnoila IR, Belinsky SA, Harris
CC and Dennis PA: Tobacco carcinogen-induced cellular
transformation increases activation of the phosphatidylinositol
3′-kinase/Akt pathway in vitro and in vivo. Cancer Res. 64:446–451.
2004.PubMed/NCBI
|
|
20
|
Hsu NY, Ho HC, Chow KC, et al:
Overexpression of dihydrodiol dehydrogenase as a prognostic marker
of non-small cell lung cancer. Cancer Res. 61:2727–2731.
2001.PubMed/NCBI
|
|
21
|
Deng HB, Parekh HK, Chow KC and Simpkins
H: Increased expression of dihydrodiol dehydrogenase induces
resistance to cisplatin in human ovarian carcinoma cells. J Biol
Chem. 277:15035–15043. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang HW, Lin CP, Chiu JH, et al: Reversal
of inflammation-associated dihydrodiol dehydrogenases (AKR1C1 and
AKR1C2) overexpression and drug resistance in nonsmall cell lung
cancer cells by wogonin and chrysin. Int J Cancer. 120:2019–2027.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin TS, Chiou SH, Wang LS, et al:
Expression spectra of matrix metalloproteinases in metastatic
non-small cell lung cancer. Oncol Rep. 12:717–723. 2004.PubMed/NCBI
|
|
24
|
Chen DR, Chu CY, Chen CY, et al:
Expression of short form oncostatin M receptor as a decoy receptor
in lung adenocarcinomas. J Pathol. 215:290–299. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen JT, Lin TS, Chow KC, et al: Cigarette
smoking induces overexpression of HGF in type II pneumocytes and
lung cancer cells. Am J Repir Cell Mol Biol. 34:264–273. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen JT, Huang CY, Chiang YY, et al: HGF
increases cisplatin resistance via down-regulation of AIF in lung
cancer cells. Am J Respir Cell Mol Biol. 38:559–565. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yano S, Wang W, Li Q, et al: Hepatocyte
growth factor induces gefitinib resistance of lung adenocarcinoma
with epidermal growth factor receptor-activating mutations. Cancer
Res. 68:9479–9487. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mountain CF: Revisions in the
international system for staging lung cancer. Chest. 111:1710–1717.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Remmele W and Schicketanz KH:
Immunohistochemical determination of estrogen and progesterone
receptor content in human breast cancer. Computer-assisted image
analysis (QIC score) vs subjective grading (IRS). Pathol Res Pract.
189:862–866. 1993. View Article : Google Scholar
|
|
30
|
Kaplan EL and Meier P: Nonparametric
estimation from incomplete observations. J Am Stat Assoc.
53:457–481. 1958. View Article : Google Scholar
|
|
31
|
Mantel N: Evaluation of survival data and
two new rank order statistics arising in its consideration. Cancer
Chemother Rep. 50:163–170. 1966.PubMed/NCBI
|
|
32
|
Swanton C, Futreal A and Eisen T:
Her2-targeted therapies in non-small cell lung cancer. Clin Cancer
Res. 12:4377s–4383s. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chiang YY: Hepatocyte growth factor
induces hypoxia-related interleukin-8 expression in lung
adenocarcinoma cells. Mol Carcinog. 48:662–670. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ma PC, Jagadeeswaran R, Jagadeesh S, et
al: Functional expression and mutations of c-Met and its
therapeutic inhibition with SU11274 and small interfering RNA in
non-small cell lung cancer. Cancer Res. 65:1479–1488. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kastan MB and Bartek J: Cell-cycle
checkpoints and cancer. Nature. 432:316–323. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lim ST, Chen XL, Lim Y, et al: Nuclear FAK
promotes cell proliferation and survival through FERM-enhanced p53
degradation. Mol Cell. 29:9–22. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mitra SK and Schlaepfer DD:
Integrin-regulated FAK-Src signaling in normal and cancer cells.
Curr Opin Cell Biol. 18:516–523. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shiloh Y: ATM and related protein kinases:
safeguarding genome integrity. Nat Rev Cancer. 3:155–168. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Myers K, Gagou ME, Zuazua-Villar P,
Rodriguez R and Meuth M: ATR and Chk1 suppress a
caspase-3-dependent apoptotic response following DNA replication
stress. PLoS Genet. 5:e10003242009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tsai CM, Chang KT, Wu LH, et al:
Correlations between intrinsic chemoresistance and HER-2/neu gene
expression, p53 gene mutations, and cell proliferation
characteristics in non-small cell lung cancer cell lines. Cancer
Res. 56:206–209. 1996.PubMed/NCBI
|
|
41
|
Noro R, Gemma A, Kosaihira S, et al:
Gefitinib (IRESSA) sensitive lung cancer cell lines show
phosphorylation of Akt without ligand stimulation. BMC Cancer.
6:2772006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
King FW, Skeen J, Hay N and Shtivelman E:
Inhibition of Chk1 by activated PKB/Akt. Cell Cycle. 3:634–637.
2004.PubMed/NCBI
|
